20 research outputs found
Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes
Get PDF<p>Abstract</p> <p>Herein, we describe recruitment efforts for a trial of lipid-lowering medications in adolescents with type 1 diabetes, age 12–21 years. Based on our experience, future studies will require multiple centers to enroll a sufficient number of participants for adequate data to direct dyslipidemia medication treatment guidelines for adolescents with type 1 diabetes.</p
Arterial Stiffness, Lipoprotein Particle Size, and Lipoprotein Particle Concentration in Children with Type 1 Diabetes
No full textComorbidities and microvascular complications of type 2 diabetes in children and adolescents
No full textObesity and dyslipidemia – An urgent matter in youth from the general population and in type 1 diabetic patients
No full text
Dyslipidemia in adolescents and young adults with type 1 and type 2 diabetes: a retrospective analysis
No full textAntidyslipidemic Effect of Ocimum sanctum Leaf Extract in Streptozotocin Induced Diabetic Rats
No full textResponsibility, inequality, efficiency, and equity in four sustainability paradigms: insights for the global environment from a cross-development analytical model
No full text
